BHUTAN BIOTECHNOLOGY ENTERPRISE (UK) CO. LIMITED

Company Registration Number:
13647704 (England and Wales)

Unaudited micro entity accounts for the year ended 30 September 2024

Period of accounts

Start date: 01 October 2023

End date: 30 September 2024

BHUTAN BIOTECHNOLOGY ENTERPRISE (UK) CO. LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

BHUTAN BIOTECHNOLOGY ENTERPRISE (UK) CO. LIMITED

Company Information

for the Period Ended 30 September 2024




Registered office: Suite G04
1 Quality Court, Chancery Lane
London
England
WC2A 1HR
Company Registration Number: 13647704 (England and Wales)

BHUTAN BIOTECHNOLOGY ENTERPRISE (UK) CO. LIMITED

Profit and Loss Account

for the Period Ended 30 September 2024


2024
£

2023
£
Turnover 6,343 6,243
Cost of Materials ( 3,429 ) ( 3,750 )
Other charges ( 4,021 ) ( 3,826 )
Profit or (Loss) for Period ( 1,107 ) ( 1,333 )

BHUTAN BIOTECHNOLOGY ENTERPRISE (UK) CO. LIMITED

Balance sheet

As at 30 September 2024


2024
£

2023
£
Current assets: 20 19
Prepayments and accrued income: 200
Creditors: amounts falling due within one year: ( 2,659 ) ( 1,351 )
Net current assets (liabilities): ( 2,439 ) ( 1,332 )
Total assets less current liabilities: ( 2,439 ) ( 1,332 )
Total net assets (liabilities): ( 2,439 ) ( 1,332 )
Capital and reserves: ( 2,439 ) ( 1,332 )

BHUTAN BIOTECHNOLOGY ENTERPRISE (UK) CO. LIMITED

Balance sheet continued

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 30 June 2025
And Signed On Behalf Of The Board By:

Name: Wai Ming Lo
Status: Director

The notes form part of these financial statements

BHUTAN BIOTECHNOLOGY ENTERPRISE (UK) CO. LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 September 2024

  • 1. Employee Information

    Average number of employees: 0

BHUTAN BIOTECHNOLOGY ENTERPRISE (UK) CO. LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 September 2024

  • 2. Off balance sheet disclosure

    No